CONy 4 Barceona
    Topics
    Abstracts
    Registration
    Accommodation
    Contact
     Home
     Welcome Note
     Congress Chairpersons
     Section Heads
     Committees
     Faculty
     Timetable
     Scientific Topics
     Scientific Program
     Poster presentations
         Guided Poster Tours
         Poster Presentation Guidelines
         Best Poster Prize
     Registration
         Accompanying Persons Program
     Sponsorship & Exhibition
     Sponsors
     Accommodation
         Hotel Rey Juan Carlos
         Hotel Husa Arenas
         Hotel Husa Illa
         Hotel Senator Barcelona
     CME
     General Information
         About Barcelona
         Italian Agent
         Before you travel...
     Webcasting
     Invitation Letter
     Partners
     Past & Future CONy Congresses
The 4th World Congress on
Controversies in Neurology (CONy)
Barcelona, Spain, Palau de Congressos de Catalunya, October 28-31, 2010
 
  Webcasting - Selected Topics Print
Thursday, October 28, 2010
 
Plenary Session II
FREE ACCESS JOURNALS ARE IMPORTANT AND USEFUL: PRO
W. Theodore
FREE ACCESS JOURNALS ARE IMPORTANT AND USEFUL: CON
R. Castellani
IS ALZHEIMER'S DISEASE A HOMOGENEOUS NOSOLOGIC ENTITY? YES
P. Martinez Martin
IS ALZHEIMER'S DISEASE A HOMOGENEOUS NOSOLOGIC ENTITY? NO
A.D. Korczyn

Friday, October 29, 2010
Hall A - Epilepsy
 
Session 1 Epilepsy: Less Conventional Treatments
SHOULD HORMONAL THERAPY BE USED TO TREAT EPILEPSY? YES
E. Ben-Menachem
HORMONAL THERAPY SHOULD NOT BE USED TO TREAT EPILEPSY
M. Sperling
COMMENT
M. Carreno Martinez
SHOULD RECENTLY APPROVED ANTIEPILEPTIC DRUGS (AEDS) BE USED EARLY IN THE TREATMENT OF EPILEPSY? THE ANSWER IS YES
D. Schmidt
SHOULD RECENTLY APPROVED ANTIEPILEPTIC DRUGS (AEDS) BE USED EARLY IN THE TREATMENT OF EPILEPSY? NO
E. Beghi
COMMENTARY
M. Sperling
 
 
Session 2 Epilepsy: Psychological Aspects
 
SHOULD PATIENTS WITH EPILEPSY WHO ARE DEPRESSED BE ROUTINLY TREATED WITH ANTIDEPRESSANT MEDICATION OR VAGUS NERVE STIMULATION? VNS
E. Ben-Menachem
SHOULD PATIENTS WITH EPILEPSY WHO ARE DEPRESSED BE ROUTINLY TREATED WITH ANTIDEPRESSANT MEDICATION OR VAGUS NERVE STIMULATION? ADM
D. Schmidt
COMMENTARY
W. Theodore

Saturday, October 30, 2010
Hall A - Multiple Sclerosis
 
Session 14: Etiology and Pathogenesis of MS
DOES CHRONIC VENOUS INSUFFICIENCY PLAY A ROLE IN MS PATHOGENESIS? YES
P. Zamboni
DOES CHRONIC VENOUS INSUFFICIENCY PLAY A ROLE IN MS PATHOGENESIS? NO
O. Stüve
COMMENTARY
A. Miller
ARE INFECTIONS KEY ENVIRONMENTAL FACTORS IN MS? NO
A. Chaudhuri
 
Session 16: New Players in MS
SHOULD ALL MS PATIENTS BE TREATED WITH STATINS? YES
O. Stüve
SHOULD ALL MS PATIENTS BE TREATED WITH STATINS? NO
R. Milo
FUMARATE
J. Losy
BONE MARROW TRANSPLANTATION
D. Karussis
TERIFLUNOMIDE
M. Freedman
LAQUINIMOD
P. Vermersch
CLADRIBINE
P. Rieckmann
EMERGING TREATMENTS FOR PSEUDOBULBAR AFFECT
D. Wynn
 
Saturday, October 30, 2010
Hall B - Headache / Pain

 
Session 19 Headache: What causes post traumatic headache - Will CRGP antagonists be effective?
WILL THE FIRST MARKETED CGRP ANTAGONIST BE AN IMPORTANT ADDITION TO THE MIGRAINE TREATMENT ARMAMENTARIUM? YES
A. Rapoport
WILL THE FIRST MARKETED CGRP ANTAGONIST BE AN IMPORTANT ADDITION TO THE MIGRAINE TREATMENT ARMAMENTARIUM? NO
M. Levin
COMMENTARY
N. Mathew
 
Session 28: Biomarkers in Diagnositcs of Neurological Disorders
THE PLACE OF SURROGATE ENDPOINTS IN THE DEVELOPMENT OF NEW NEUROLOGICAL MEDICINES
P. Feldschreiber

Home    Contact Us   
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 04/11/2012 Created by     WebStudio.co.il